In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)


Class-Action Tracker

Zantac Heartburn Medication

Class Action

Zantac Heartburn Medication

In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…


The Latest

Filters

Pacagen

Ad Alert

Pacagen

Will this cat company give you the purrfect allergy relief?

Billionaire Casino

Ad Alert

Billionaire Casino

Regulator finds TikTok ads misled consumers into thinking they could win real-world prizes.


Show More